Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.
about
A parathyroid hormone antagonist stimulates epidermal proliferation and hair growth in miceThe molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related familiesGenes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityCrystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytesDifferential regulation of epidermal function by VDR coactivatorsVitamin D metabolism and function in the skin.Vitamin D and the skin: Physiology and pathophysiology.Oral vitamin D, still a viable treatment option for psoriasis.Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis.Protective actions of vitamin D in UVB induced skin cancer.Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytesNovel topical therapy for mild-to-moderate plaque psoriasis: focus on calcitriol.Optimal differentiation of in vitro keratinocytes requires multifactorial external control.Vitamin D regulated keratinocyte differentiation: role of coactivators.Vitamin D analogues and psoriasis.Calcipotriol and psoriasis.1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels.Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas.Resurgence of vitamin D: Old wine in new bottleRegulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion.Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba.A new insight into the role of rat cytochrome P450 24A1 in metabolism of selective analogs of 1α,25-dihydroxyvitamin D₃.Preliminary evidence for vitamin D deficiency in nodulocystic acne.Vitamin D receptor gene polymorphisms and haplotypes (Apa I, Bsm I, Fok I, Taq I) in Turkish psoriasis patientsVitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate.Cloning of the human phospholipase C-gamma1 promoter and identification of a DR6-type vitamin D-responsive element.Significant independent predictors of vitamin d deficiency in inpatients and outpatients of a nephrology unit.Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research.Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood.Epidermal growth.Vitamin D metabolite production and function in keratinocytes.Actions of 1 alpha,25-dihydroxyvitamin D3 on normal, psoriatic, and promoted epidermal keratinocytes.Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases.Skin: site of the synthesis of vitamin D and a target tissue for the active form, 1,25-dihydroxyvitamin D3.A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis.Therapeutic progress. II: Treatment of psoriasis.
P2860
Q24317080-C59C6451-4961-4D95-8714-131A96A802EFQ24620035-392A7C11-D4DB-41B7-A4CC-9259E506BC85Q24679438-E4B242D1-6FB5-4A01-88EF-D46E8B77F721Q27678429-ABE60E0D-3B76-45DF-8A68-241C7851679DQ28370439-7852CF73-2DFB-438E-A5E7-832062150B3FQ33542906-4ED9CB7D-1B64-40EF-A2EE-589CD7B5F561Q33929850-598B1CDE-30E8-49EB-A3FD-EC1ED1B242DFQ33993788-73494C47-8CD7-4F29-B7FA-3A6044F42FB0Q34234791-05EEE8B7-C71E-4644-9E77-82B7F1E34399Q34334744-4CC67BDE-7590-431E-8AC2-6F05E772381BQ34418244-FBE14B3F-F98B-46DB-89F8-74BB4AFEA61CQ34567983-B33B037C-48DE-4C7B-AC2A-A8A58EC467DBQ34620250-87787CE6-42E0-449C-8A4D-7B7EB1DAF76CQ35015173-2035F18B-99C1-4C57-93E3-698D2413919AQ35042188-2097226A-2966-42DA-BF72-2E380D315478Q35358439-90A12844-4493-4EF0-BEFE-44F578F3E38EQ35505870-7FFF40B1-1822-44EC-9CFD-56844C8F60FEQ35751427-850B41B1-F170-4C13-94D9-391D60CB337AQ35787799-9A796B7D-2DD7-4E8C-AD99-DBD613C71F21Q35806866-CDC73171-5EA6-4EEC-B2CD-C71049BB8B3CQ35819530-3A1EE8B4-279E-4A7C-926F-8F80CB55E230Q35942462-D1D7BC89-8894-402A-95FB-C504F4001DBBQ36008987-CB522750-975B-42E5-8DA3-8EA12739BF8EQ36086022-4D383C62-0814-4712-8A35-89B34447F0E2Q36576962-D9EF75EE-83FE-4FFE-A18B-148F56AF4D97Q36582956-F400CF27-398E-4CA2-9312-C706C4EEB5E7Q36847893-975863C1-C41B-4C2F-9548-BD480EB6F81BQ36869308-ED590E24-043B-476A-B21C-E0A01732CB6CQ36917184-B64D2C07-BB57-4061-94C9-57E68438B6E1Q37959978-BDB61201-C938-4AF7-93F5-E7AD342694C1Q38110436-4F225B0F-455C-448F-AEF0-0966E0556F96Q38189981-FEF5130D-3524-4519-ADB9-B7B0F5CC21D0Q38202247-907A361D-5D94-423A-ADF2-AE081F4085CCQ38202253-E82E657B-1F4B-4120-93C8-98CE8E6A21B2Q38905499-C28F4485-899C-46CF-B7A9-9371B6695A68Q39023042-5428FD1A-D090-41A2-BDDC-4516370FA56AQ39067901-D7E54320-1A38-4D6C-B67D-56D07F73ECF8Q39331877-4A6C3186-CA60-43F3-BCBC-2670E7E2B94BQ39634170-743C29AE-7060-49E1-9D0E-A63374F6C0B6Q40395262-9FD6D225-2CED-417C-A03F-7D79E51F26F6
P2860
Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@ast
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@en
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@nl
type
label
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@ast
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@en
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@nl
prefLabel
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@ast
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@en
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@nl
P1476
Effect of 1 alpha,25-dihydroxy ...... rown in serum-free conditions.
@en
P2093
P2888
P304
P356
10.1111/1523-1747.EP12276343
P407
P577
1986-06-01T00:00:00Z
P5875
P6179
1043713698